網路內科繼續教育
有效期間:民國 94年03月01日 94年03月15日

    Case Discussion

Chief complain: 

       Fever and abdominal discomfort for one day

Brief History: 

       This 50-year- old man was a victim of chronic hepatitis B virus infection with abnormal liver function for more than ten years, but he did not get regular medical follow-ups. He has suffered from general malaise two days before admission and only took some medicine for common cold from local hospital. Fever flared up one day later and he took antipyretics during the febrile periods. However, his general malaise became more severe, and was accompanied with insomnia and abdominal discomfort. There was no other associated symptom such as nausea, vomiting, diarrhea or constipation. He was sent to our emergency room at 4: 00 AM in the morning.

      At emergency room, the pulse rate was 82/min, the respiratory rate was 21/min, and the blood pressure was 94/59 mmHg. He had a mild fever of 37.5 degrees Celsius. His consciousness was clear and oriented. The sclera was icteric and pupils were 3mm/3mm in size with prompt light reflex. The throat was not injected. The neck was supple and the breath sounds were clear. The heart sounds were regular without audible murmur. The abdomen was soft but distended. Mild tenderness in the epigastric area was noted without peritoneal signs or Murphy's sign. The four limbs were freely movable without edema. No infectious skin lesion was found. The initial laboratory examination revealed thrombocytopenia, mild jaundice, azotemia and severe metabolic acidosis (Table 1). Abdominal sonography revealed liver cirrhosis, splenomegaly, and mild thickening of the gall bladder. There was no pneumonic patch in the chest X-ray film (Figure 1 ). Under the impression of sepsis that was possibly related to spontaneous bacterial peritonitis cefoxitin was given. However, abdominal pain aggravated, and a subcutaneous shot of Keto was given around at 3:00 PM. A sudden onset of conscious change and apnea developed at 3:20 PM. After cardiopulmonary resuscitation spontaneous circulation was restored 3 minutes later. Then he was sent to intensive care unit.

      In the intensive care unit, he remained in a state of deep coma with rigidity of four limbs. Bediseds, acute renal failure, hyperkalemia, hypernatremia, rhabdomyolysis, hyperammonemia, elevated transaminases, hyperbilirubinemia, and prolonged PT/PTT were found. Computer tomography of the head showed a subdural hematoma on the left side. Neurosurgeon suggested that surgical intervention was unfeasible due to poor general condition of the patient. Antibiotics were shifted to imipenam + penicillin G under the impression of sepsis with multiple organ failure. Fluid supplement, bicarbonaste infusion, calcium gluconate, insulin + glucose and cation exchange resin were given to correct the metabolic acidosis and hyperkalemia. Transfusion of fresh frozen plasma was given to correct the bleeding tendency. Pulseless ventricular tarchycardia developed 30minutes after arrival at the intensive care unit and was successfully converted to sinus rhythm by electrical cardioversion. However, refractory hyperkalemia with marked EKG change (Figure 2 ) was ensued despite of aggressive medical treatment and administration of large amount of bicarbonate. Profound shock and anuria also developed. The patient's family refused to receive emergent renal replacement therapy and further resuscitation for the patient. The patient passed away at 6:12 PM on the day of admission.

      The blood culture grew Group G Streptococcus two days after admission.

Final diagnosis:

  1. Group G Streptococcal bacteremia with streptococcal toxic shock syndrome and multiple organ failure.
  2. Liver cirrhosis, HBV related
  3. Subdura hematoma, left frontoparietal area

Discussion:

       This is a case of severe presentation of group G streptococcal infection with toxic shock syndrome. The severe metabolic catabolism by DIC and metabolic acidosis with renal failure caused intractable hyperkalemia. These factors resulted in the cardiovascular collapse and led to death of this patient.

      Group G streptococcus is beta-hemolytic bacteria that occasional cause human infection similar to those caused by Group A streptococcus, including pharyngitis, pneumonia, cellulites and soft tissue infection, arthritis, septic arthritis and endocarditis. A case definition of streptococcal toxic shock syndrome was formulated in 1993 (Table 2). The syndrome is often associated with underlying disease such as malignancy, DM, cirrhosis, alcohol/drug abuse, ESRD, steroid use, heart disease, postpartum status, degenerative joint and child/old age. The bacteria usually colonize at pharynx, skin, genitals and GI tract. Skin is the most common port of entry, followed by respiratory tract and GU tract. The most common associated infection is soft tissue infection including necrotizing fasiitis, myocitis, or cellulites. But, up to 50% patients did not reveal any portal of entry. In this patient no prominent infection focus was found. Exactly why patients develop streptococcal toxic shock syndrome is unknown. Studies of these patients demonstrated strong association of certain streptococcal strains producing streptococcal exotoxin A, B or C was associated this syndrome. The exotoxin could act as superantigen, bind to both MHC complex of antigen-presenting cells and Vβregion of T-cell receptors. T-cell proliferate, then produce IL-1, TNFα, TNFβ, IL-6, γ-INF, bradykinin. The general features are usually presented with various prodromes such as fever, nausea, malaise and mental confusion, which rapidly deteriorate to hypotension, renal impairment, respiratory distress syndrome and shock. Laboratory abnormalities include a marked shift to the left in the white blood cell differential with many immature granulocytes; hypocalcemia; hypoalbuminemia; and thrombocytopenia, which usually becomes more pronounced on the secondary or third day of illness. Streptococcal toxic syndrome is associated with a mortality rat of 30~70 percent, with most death secondary to shock or respiratory failure. Because of the high mortality of this syndrome, once the syndrome is suspected patients should be given aggressive therapy. These include fluid resuscitation, pressors, and mechanical ventilation in addition to antimicrobial therapy. The underlying infection should be managed, such as necrotizing fasciitis should be managed with surgical debridement. Penicillin is the choice of antimicrobial therapy. Some authors advocated that treatment with clindamycin should be considered, which through its direct action on protein synthesis, clindamycin is more effective in rapidly terminating toxin production than penicillin. Intravenous immunoglobulin has been suggested as adjunctive therapy for streptococcal toxic syndrome; pooled immunoglobulin preparation is likely to contain antibodies capable of neutralizing the effects of streptococcal toxin.

Table 1
< Laboratory Examination >

1. Hemogram
 

WBC
K/μL 

 RBC
M/μL 

Hb
g/dL

Hct
 %

MCV
FL

PLT
K/μL

Myelo
%

Meta
%

Band
%

 Seg
%

Eos
%

Lym
%

8:30AM

3.63

4.39

16.4

45.1

102.7

26

0

4

52

 7

0

22

3:30PM

5.4

3.97

14.9

40.7

102.5

34

2

9

50

16

0

14


2. Biochemistry
 

Albumin
g/dL

T-Bil
mg/dL

D-Bil 
mg/dL

AST
U/L 

ALT
U/L

Lipase
U/L

ALP
U/L

CK/MB
U/L 

Tn-I
ng/mL

8:30AM

 3.16

3.99

2.35

212

120

15

190

 

 

3:30PM

11.04

 

317

127

 

313

5230/125.8

0.495

6:00PM

2.28

11.17

8.83

622

300

 

 

9567/252

3.41

 

BUN
Mg/dL

Cre
Mg/dL

Na
mmol/L

K(H)
 mmol/L  

Ca 
mmol/L

P
Mg/dL

Mg
mmole/L 

NH3
Umol/L

Lactate
Mmol/L

8:30AM

27.3

2.1

139

4.7

 2.25

 

 

 36

 

3:30PM

32.2

2.4

161

 5.2(2+)

1.90

 

 

230

>12

6:00PM

 

 

142

10.6(4+)

3.21

22.9

1.73    

 

 

3. ABG:
 

PH

PCO2

PO2

HCO3

BE

FiO2

8:30AM

7.18

 35.6

53.7

12.8

-14.

Room Air

3:30PM

7.06

19.8

94.0

 5.4

-25.4

100%

6:00PM

7.42

41.6

78.1

27.7

+3.0

100%

4. Coagulation profile
 

PT (sec)

PTCont. (sec)

PT INR

PTT(sec)

PTTCont.

4:30PM

36.6

13.0

3.0

127.0

37.4

6:00PM

56.3

12.4

4.3

216

35.2

5PM, Fibrinogen: 201(mg/dl), 3P: 4+, FDP>1280(mcg/dl), D-Dimer: 50.42(mcg/dl)
Final blood culture report: Group G Streptococcus (II/II)

Table 2
 Proposed Case Definition of the Streptococcal Toxic Shock Syndrome
  1. Isolation of Streptococcus
    A. From a normally sterile site
    B. From a nonsterile site
  2. Clinically signs of severity

    1. Hypotension (systolic pressure < =  90 mmHg in adults or in the 5th   percentile for age in children.

                                         and

    2. Two or more of the following signs:
      - Renal impairment
      - Coagulopathy  or disseminated intravascular coagulation
      - Liver dysfunction (elevated GOT/GPT, bilirubin)
      - ARDS
      - A generalized erythematous macular rash, may desquamate
      - Soft tissue necrosis (necrotizing fascitis, myositis, gangrene)

An illness fulfilling criteria IA, IIA, and IIB is defined as a definite case. An illness fulfilling criteria IB, IIA, and IIB is defined as probable case if no other etiology is identified.

繼續教育考題
1.
(D)
Which underling disease is associated with streptococcal toxic shock syndrome?
A DM
B Cirrhosis
C Postpartum status
D All of the above
2.
(B)
Which site is the most frequent portal entry of streptococcus in streptococcal toxic shock syndrome?
A Genitourinary tract
B Skin
C Respiratory tract
D Gastrointestinal tract
3.
(B)
Which drug is the choice of antimicrobial therapy in streptococcal toxic shock syndrome?
A Tetracycline
B Penicillin
C Chloramphenicol
D Metronidazole
4.
(E)
Which one below is the clinical presentation in streptococcal toxic shock syndrome?
A Isolation of streptococcus
B Hypotension
C Organ failure (such as liver, kidney or lung)
D Disseminated intravascular coagulation
E All of the above
5.
(D)
Which statement about streptococcal toxic shock syndrome (STSS) is wrong?
A The prodrome of STSS includes malaise, nausea and fever.
B The mortality of STSS is high.
C Development to shock is usually seen in STSS.
D Antimicrobial therapy only is adequate and fluid supplement is not necessary in STSS patient.
6.
(E)
Which laboratory abnormality is usually seen in streptococcal toxic shock syndrome?
A Leukocytosis with left shift
B Hypocalcemia
C Hypoalbuminemia
D Thrombocytopenia
E All of the above
7.
(C)
The most common associated infection in streptococcal toxic shock syndrome is
A Pharyngitis
B Endocarditis
C Soft tissue infection
D Peritonitis
8.
(E)
Which statement about streptococcal toxic shock syndrome (STSS) is right?
A Other group of streptococcus such as group A could also results in STSS
B The streptococcal exotoxin B or C is reported to be related to STSS.
C The differential diagnosis between staphylococcal and streptococcal toxic shock syndrome could be clinically indistinguishable.
D Supportive treatment such as dialysis or ventilatory support is necessary in patients with renal or respiratory failure.
E All of the above
9.
(D)
Which strategy is right for the management of streptococcal toxic shock syndrome?
A Early use of antimicrobial therapy against streptococcus before the ulture is reported
B Pay attention to the sign of streptococcal infection, such as skin infection symptom and sign
C Aggressive supportive therapy including fluid supplement and pressor agents
D All of the above
10.
(D)
What is the role of exotoxin in streptococcal toxic shock syndrome?
A Bind to T cell receptor and MHC complex of antigen presenting cell
B Activate T cell
C Stimulate T cell to secret pro-inflammatory cytokine, such as TNF-a, IL-1b
D All of the above


Top of Page